BioWorld Asia

March 3, 2004

View Archived Issues

Oncology-Focused Igeneon Raises EUR26.7M, Ponders IPO

Igeneon AG raised €26.7 million in a third-round venture financing and landed Burrill & Co., of San Francisco, as a co-lead investor. (BioWorld International) Read More

Active Biotech Cuts Work Force; Focus Now On Current Portfolio

Read More

How Salmonella Coaxes Gut Cell To Give Warm Embrace

Read More

Monsanto GM Rapeseed Product Receives EU Scientific Clearance

Read More

Phytopharm Raises £6.5M, Plans Partnering Of Obesity Drug P57

Read More

NCI Begins Exploratory Cancer Trials With Xenova's Tariquidar

Read More

Start-Up Vaxon Seeking EUR7M For Novel Cancer Vaccines

Read More

Other News To Note

Read More